These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30311580)

  • 1. The Mechanisms of Dietary Phytoestrogen as a Potential Treatment and Prevention Agent against Alzheimer's Disease.
    Hussain A; Tabrez ES; Muhammad A; Peela JR
    Crit Rev Eukaryot Gene Expr; 2018; 28(4):321-327. PubMed ID: 30311580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Beneficial Role of Natural Endocrine Disruptors: Phytoestrogens in Alzheimer's Disease.
    Domańska A; Orzechowski A; Litwiniuk A; Kalisz M; Bik W; Baranowska-Bik A
    Oxid Med Cell Longev; 2021; 2021():3961445. PubMed ID: 34527172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytoestrogens and cognitive function: a review.
    Soni M; Rahardjo TB; Soekardi R; Sulistyowati Y; Lestariningsih ; Yesufu-Udechuku A; Irsan A; Hogervorst E
    Maturitas; 2014 Mar; 77(3):209-20. PubMed ID: 24486046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key Peptides and Proteins in Alzheimer's Disease.
    Penke B; Bogár F; Paragi G; Gera J; Fülöp L
    Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease.
    Scheltens P; Blennow K; Breteler MM; de Strooper B; Frisoni GB; Salloway S; Van der Flier WM
    Lancet; 2016 Jul; 388(10043):505-17. PubMed ID: 26921134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
    Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T
    Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An antioxidant specifically targeting mitochondria delays progression of Alzheimer's disease-like pathology.
    Stefanova NA; Muraleva NA; Maksimova KY; Rudnitskaya EA; Kiseleva E; Telegina DV; Kolosova NG
    Aging (Albany NY); 2016 Oct; 8(11):2713-2733. PubMed ID: 27750209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ilex latifolia Prevents Amyloid β Protein (25-35)-Induced Memory Impairment by Inhibiting Apoptosis and Tau Phosphorylation in Mice.
    Kim JY; Lee HK; Jang JY; Yoo JK; Seong YH
    J Med Food; 2015 Dec; 18(12):1317-26. PubMed ID: 26291170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of Alzheimer's disease.
    Gooch MD; Stennett DJ
    Am J Health Syst Pharm; 1996 Jul; 53(13):1545-57; quiz 1603-4. PubMed ID: 8809275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease; taking the edge off with cannabinoids?
    Campbell VA; Gowran A
    Br J Pharmacol; 2007 Nov; 152(5):655-62. PubMed ID: 17828287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.
    Barage SH; Sonawane KD
    Neuropeptides; 2015 Aug; 52():1-18. PubMed ID: 26149638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Vitamin E in the Treatment of Alzheimer's Disease: Evidence from Animal Models.
    Gugliandolo A; Bramanti P; Mazzon E
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro neuroprotective effects of naringenin nanoemulsion against β-amyloid toxicity through the regulation of amyloidogenesis and tau phosphorylation.
    Md S; Gan SY; Haw YH; Ho CL; Wong S; Choudhury H
    Int J Biol Macromol; 2018 Oct; 118(Pt A):1211-1219. PubMed ID: 30001606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of the cholinergic system in the brain during aging and in Alzheimer's disease.
    Schliebs R; Arendt T
    J Neural Transm (Vienna); 2006 Nov; 113(11):1625-44. PubMed ID: 17039298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Puerarin attenuates amyloid-beta-induced cognitive impairment through suppression of apoptosis in rat hippocampus in vivo.
    Li J; Wang G; Liu J; Zhou L; Dong M; Wang R; Li X; Li X; Lin C; Niu Y
    Eur J Pharmacol; 2010 Dec; 649(1-3):195-201. PubMed ID: 20868658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive enhancement therapy for Alzheimer's disease. The way forward.
    Parnetti L; Senin U; Mecocci P
    Drugs; 1997 May; 53(5):752-68. PubMed ID: 9129864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.